The combination effect of sodium butyrate and 5-Aza-2′-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines

World Journal of Surgical Oncology

Volumn 7, Issue , 2009, Pages

  Cho, Hang Joo ^a   Kim, Sin Young ^a   Kim, Kee Hwan ^a   Kang, Won Kyung ^b   Kim, Ji Il ^a   Oh, Seong Tack ^b   Kim, Jeong Soo ^a   An, Chang Hyeok ^a  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BINDING PROTEIN; BUTYRIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN MINT1; PROTEIN MINT2; PROTEIN MINT3; UNCLASSIFIED DRUG; UVOMORULIN; AZACITIDINE; BUTYRIC ACID DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; HISTONE DEACETYLASE; RADIOSENSITIZING AGENT;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CELL STRAIN MCF 7; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; DOUBLE STRANDED DNA BREAK; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; MONOTHERAPY; POLYMERASE CHAIN REACTION; RADIATION DOSE; RADIOSENSITIVITY; BREAST TUMOR; COLORECTAL TUMOR; DRUG ANTAGONISM; FEMALE; PATHOLOGY; TUMOR CELL LINE;

AZACITIDINE; BREAST NEOPLASMS; BUTYRATES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; ENZYME INHIBITORS; FEMALE; HISTONE DEACETYLASES; HUMANS; RADIATION DOSAGE; RADIATION-SENSITIZING AGENTS;

EID: 67649659846     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-7-49     Document Type: Article

References (29)

1. Verma M Srivastava S Epigenetics in cancer: Implications for early detection and prevention Lancet Oncol 2002, 3:755-763. 10.1016/ S1470-2045(02)00932-4 12473517
2. Jones PA Baylin SB The fundamental role of epigenetic events in cancer Nat Rev Genet 2002, 3:415-428. 10.1038/nrg962 12042769
3. Syzf M Pakneshan P Rabbiani SA DNA methylation and breast cancer Biochem Pharmacol 2004, 68:1187-1197. 10.1016/j.bcp.2004.04.030 15313416
4. Garinis GA Patrinos GP Spanakis NE Menounos PG DNA hypermethylation: when tumor suppressor genes go silent Hum Genet 2002, 111:115-127. 10.1007/s00439-002-0783-6 12189484
5. Narlikar GJ Fan HY Kingstone RE Cooperation between complexes that regulate chromatin structure and transcription Cell 2002, 108:475-487. 10.1016/S0092-8674(02)00654-2 11909519
6. Marks P Rifkind RA Richon VM Breslow R Miller T Kelly W Histone deacetylase and cancer: Causes and therapies Nat Rev Cancer 2001, 1:194-202. 10.1038/35106079 11902574
7. Walton TJ LI G Seth R McArdle SE Bishop MC Rees RC DNA Demethylation and Histone Deacetylation Inhibition Co-Operate to Re-Express Estrogen Receptor Beta and Induce Apoptosis in Prostate Cancer Cell-lines Prostate 2008, 68:210-222. 10.1002/pros.20673 18092350
8. Murakami J Asaumi J Maki Y Tsujigiwa H Kuroda M Nagai N Yanagi Y Inoue T Kawasaki S Tanaka N Matsubara N Kishi Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines Oral Oncol 2004, 40:597-603. 10.1016/j.oraloncology.2003.12.008 15063388
9. Bar-Sela G Jacobs KM Gius D Histone Deacetylase inhibitor and Demethylating agent chromatin compaction and the radiation response by cancer cells Cancer J 2007, 13:65-69. 10.1097/PPO.0b013e31803c7565 17464248
10. Zhu WG Otterson GA The interaction of histone deactylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells Curr Med Chem Anticancer Agents 2003, 3:187-199. 10.2174/ 1568011033482440 12769777
11. Shen WJ Dai DQ Teng Y Liu HB Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB World J Gastroenterol 2008, 14:595-600. 2681152 18203293 10.3748/wjg.14.595
12. Camphausen K Tofilon PJ Inhibition of Histone Deacetylation: A strategy for tumor radiosensitization J Clin Oncol 2007, 25:4051-4056. 10.1200/ JCO.2007.11.6202 17827453
13. Camphausen K Burgan W Cerra M Oswald KA Trepel JB Lee MJ Tofilon PJ Enhanced Radiation-induced cell killing and prolongation of rH2AX foci expression by the histone deacetylase Inhibitor MS-275 Cancer Res 2004, 64:316-321. 10.1158/0008-5472.CAN-03-2630 14729640
14. Dote H Cerna D Burgan WE Carter DJ Cerra MA Hollingshead MG Camphausen K Tofilon PJ Enhancement of In vitro and In vivo tumor cell radiosensitivity by the DNA methylation inhibitor Zebularine Clin Cancer Res 2005, 11:4571-4579. 10.1158/1078-0432.CCR-05-0050 15958643
15. Remiszewski SW Recent advances in the discovery of small molecule histone deacetylase inhibitors Curr Opin Drug Discov Devel 2002, 5:487-499. 12197307
16. Johnstome R Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer Nat Rev Drug Discov. 2002, 1(4):287-299. 10.1038/ nrd772 12120280
17. Brown CE Lechner T Howe L Workman JL The many HATs of transcription coactivators Trends Biochem Sci 2000, 25:15-19. 10.1016/ S0968-0004(99)01516-9 10637607
18. Camphausen K Scott T Sproull M Tofilon PJ Enhancement of Xenograft Tumor Radiosensitivity by the Histone Deacetylase Inhibitor MS-275 and Correlation with Histone Hyperacetylation Clin Cancer Res 2004, 10:6066-6071. 10.1158/1078-0432.CCR-04-0537 15447991
19. Arundel C Glicksman A Leith J Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate(NaB) Radiat Res 1985, 104:443-448. 10.2307/3576603 4080986
20. Ljungman M The influence of chromatin structure on the frequency of radiation-induced DNA strand breaks: A study using nuclea and nucleoid monolayers Radiat Res 1991, 126:58-64. 10.2307/3578171 2020739
21. Nackerdien Z Michie J Bohm L Chromatin decondensed by acetylation shows an elevated radiation response Radiat Res 1989, 117:234-244. 10.2307/ 3577324 2922469
22. Munshi A Kurland JF Nishikawa T Tanaka T Hobbs ML Tucker SL Ismail S Stevens C Meyn RE Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity Clin Cancer Res 2005, 11:4912-4922. 10.1158/1078-0432.CCR-04-2088 16000590
23. Chinnaiyan P Vallabhaneni G Armstrong E Huang SM Harari PM Modulation of radiation response by histone deacetylase inhibition Int J Radiat Oncol Biol Phys 2005, 62:223-229. 10.1016/j.ijrobp.2004.12.088 15850925
24. Takebayashi S Nakao M Fujita N Sado T Tanaka M Taguchi H Okumura K 5-aza-2′-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation Biochem Biophys Res Commun 2001, 288:921-926. 10.1006/ bbrc.2001.5863 11688997
25. Cameron EE Bachman KE Myohanen S Herman JG Baylin SB Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 1999, 21:103-107. 10.1038/5047 9916800
26. Yang X Phillips DL Ferguson AT Nelson WG Herman JG Davidson NE Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells Cancer Res 2001, 61:7025-7029. 11585728
27. Fuks F Burgers WA Godin N Kasai M Kouzarides T DNMT3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription EMBO J 2001, 20:2536-2544. 125250 11350943 10.1093/emboj/ 20.10.2536
28. Nan X Ng HH Johnson Ca Laherty CD Turner BM Eisenman RN Bird A Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histione deacetylase complex Nature 1998, 393:386-389. 10.1038/30764 9620804
29. De Schutter H Kimpe M Isebaert S Nuyts S A systematic assessment of radiation dose enhancement by 5-aza-2′-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 2009 73 904 12 19215824